Amanta Healthcare IPO opens today: Should you subscribe to the issue?

Amanta Healthcare IPO opens today: Should you subscribe to the issue?Amanta Healthcare plans to use ₹70 crore of the proceeds for expansion of its SteriPort manufacturing line, ₹30.1 crore for setting up a new line for SVPs, and the balance for general corporate purposes.By Meghna Sen September 1, 2025, 10:15:42 AM IST (Published)2 Min ReadThe initial public offering (IPO) of Amanta Healthcare will open for subscription on Monday, September 1. The company aims to raise ₹126 crore through the issue, which will close on Wednesday (September 3).

The Ahmedabad-based pharmaceutical company, which manufactures sterile liquid products and medical devices, will sell its shares in a fixed price band of ₹120-126. Investors can bid for a minimum of 119 shares and in multiples thereof.

The IPO is entirely a fresh issue of 1 crore shares of ₹126 crore.

Amanta Healthcare plans to use ₹70 crore of the proceeds for expansion of its SteriPort manufacturing line, ₹30.1 crore for setting up a new line for SVPs, and the balance for general corporate purposes.

Company overview

Incorporated in December 1994, Amanta Healthcare is a pharmaceutical company that specialises in the development, manufacturing, and marketing of a diverse array of sterile liquid products, specifically parenteral products, which are packaged in plastic containers utilizing Aseptic Blow-Fill-Seal (ABFS) and Injection Stretch Blow Moulding (ISBM) technologies. The company is also a manufacturer of medical devices.

The company has a strong domestic presence, with over 320 distributors and stockists, and also exports to Africa, Latin America, the UK, and other emerging markets. As of FY25, 55% of its revenue came from domestic branded generics, 33% from international sales, and 10% from product partnering and contract manufacturing.

Amanta Healthcare’s consolidated revenue stood at ₹274.7 crore in FY25, down slightly from ₹280.3 crore in FY24. Profit after tax, however, improved sharply to ₹10.5 crore in FY25 as against ₹3.6 crore in FY24.

Beeline Capital Advisors is the sole book running lead manager and MUFG Intime India is the registrar to the issue.

The allotment for the Amanta Healthcare IPO is expected to be finalised on September 4, while the company's shares will be listed on BSE and NSE with a tentative listing date fixed as September 9.Continue ReadingCheck out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!TagsIPO